PG

Priyanka Gonepally

Active Director Director DIN 11287094
DIN 11287094 First appointment Sep 2025 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value •••• Premium profile

About Priyanka Gonepally

Data last updated:

Priyanka Gonepally is a Director at Miilera Pharmaceuticals Private Limited (since 2025). The company operates in Food And Beverages. Miilera Pharmaceuticals Private Limited reported revenue of ₹98.1 Lakh (FY 2025).

DIN 11287094
Primary Designation Director
Industry Food And Beverages
First Appointment 18 Sep 2025
Oldest Company Age 7 yrs
Largest company Miilera Pharmaceuticals Private Limited · ₹98.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Sep 20252019₹98.1 Lakh (FY 2025)Active

Board colleagues of Priyanka Gonepally

Directorship timeline

Open interactive timeline →
Miilera Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Priyanka Gonepally

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka Gonepally

Priyanka Gonepally currently holds 1 directorship: Miilera Pharmaceuticals Private Limited (Director, since 18 Sep 2025, revenue ₹98.1 Lakh (FY 2025)).

Priyanka Gonepally was first appointed on 18 Sep 2025 as Director at Miilera Pharmaceuticals Private Limited.

The current boards of Priyanka Gonepally's companies include Harish Ramesh Tirmanwar (Miilera Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available